BioCentury
ARTICLE | Management Tracks

ATAI hires new CBO

Plus: Haag-Molkenteller becomes CMO at EG427, and an update from Quris 

November 30, 2022 1:12 AM UTC

Mental health disorders company ATAI Life Sciences N.V. (NASDAQ:ATAI) hired Sahil Kirpekar as CBO. Kirpekar spent eight years at Otsuka Pharmaceutical Co. Ltd. , where he was head of business development and co-chair of the global BD committee.

French gene therapies company EG 427 hired Cornelia Haag-Molkenteller as CMO. Haag-Molkenteller was CMO at Urovant Sciences Ltd., and VP and therapeutics area head in global clinical development for women’s health, internal medicine, anti-infectives and urology at Allergan Inc. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article